(Q33645887)

24886477

28 July 2017

title

Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients (English)

1 reference

28 July 2017

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Yukinori Matsuo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

7

Keiichi Nakagawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Hideomi Yamashita

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Hiroshi Onishi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Yasuo Matsumoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Takuma Nomiya

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG)

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

10 May 2014

1 reference

28 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases

6 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Management of hepatocellular carcinoma: An update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Stereotactic body radiation therapy for liver metastases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Analysis of radiation-induced liver disease using the Lyman NTCP model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Phase II study on stereotactic body radiotherapy of colorectal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Stereotactic body radiotherapy for primary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4029909

Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-112

Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients

21 January 2018

1 reference

12 December 2020

Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases

1 reference

12 December 2020

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

1 reference

12 December 2020

External beam radiotherapy to treat intra- and extra-hepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation

1 reference

12 December 2020

Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases

1 reference

12 December 2020

Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy

1 reference

12 December 2020

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

1 reference

12 December 2020

Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: retrospective study

1 reference

12 December 2020

Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-9-112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

24886477

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24886477%20AND%20SRC:MED&resulttype=core&format=json